---
title: "Matinas BioPharma Holdings, Inc. (MTNB.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/MTNB.US.md"
symbol: "MTNB.US"
name: "Matinas BioPharma Holdings, Inc."
industry: "生物技術"
---

# Matinas BioPharma Holdings, Inc. (MTNB.US)

| Item | Detail |
|------|--------|
| Industry | 生物技術 |
| Location | 美股市場 |
| Website | [www.matinasbiopharma.com](https://www.matinasbiopharma.com) |

## Company Profile

Matinas BioPharma Holdings, Inc.是一家臨床階段的生物制藥公司，利用其脂質納米晶體（LNC）平台技術識別和開發藥品。該公司的 LNC 遞送技術平台利用脂質納米晶體遞送小分子、核酸、基因療法、疫苗、蛋白質和肽。其主要產品候選藥物是 MAT2203，一種氨基糖苷類藥物的口服制劑，目前正在進行針對曲黴病和隱球菌病的第三階段臨床試驗，並用于預防因免疫抑制治療而導致的侵襲性真菌感染。它還提供 MAT2501，一種口服給藥的阿米卡星制劑

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.23 | 101/604 | - | - | - |
| PB | 0.63 | 49/604 | 1.16 | 0.72 | 0.43 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

> As of 2025-04-30T04:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 1 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.61 |

## References

- [Company Overview](https://longbridge.com/en/quote/MTNB.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/MTNB.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/MTNB.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.